News you can use about treatment and research breakthroughs

Visit Dr. Z's Medical Report

Osteoporosis drug approved for once-a-year dosing

Posted on August 21, 2007

The Food and Drug Administration has approved Reclast (zoledronic acid) injection as the first and only once-yearly treatment for postmenopausal osteoporosis. The drug is manufactured and marketed by Novartis, which also makes another formulation of the drug called Zometa, which is used in the treatment of bone disease associated with cancer.Reclast is a bisphosphonate drug and you may have heard of other oral bisphosphonates such as Fosamax (alendronate), Boniva (ibandronate) and Actonel (risedronate). The difference is that while the oral drugs have to be taken daily, weekly or monthly, Recl...

Original article link


actonel , boniva , cancer , fosamax , osteoporosis